Navigation Links
ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
Date:3/23/2009

SKILLMAN, N.J., March 23 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that Paul Moraviec has joined the company as President of its Continence and Critical Care Business Unit and ConvaTec EMEA, which includes Europe, the Middle East and Africa.

Based in Birkerod, Denmark, Moraviec will have global responsibility for the Continence and Critical Care Business Unit, a new business unit formed following ConvaTec's integration of Unomedical, a manufacturer of single-use medical devices. Additionally, he will have responsibility for the EMEA region.

Moraviec's addition completes the new leadership structure at ConvaTec. He joins Michael Steadman, President of Wound Therapeutics, and Nino Pionati, President of Ostomy Care, who recently assumed regional responsibility for ConvaTec USA and ConvaTec Intercontinental, respectively. A fourth business unit, Infusion Devices, is headed by John Lindskog. As President, Moraviec will join the company's Executive Committee.

"Paul is a proven leader with an outstanding track record of driving growth across a number of medical device specialties, making him the ideal person to leverage the newly combined product portfolio for further penetration into the acute care and home health care settings," said David Johnson, CEO, ConvaTec. "With Paul's appointment, we now have the team in place to fully capitalize on the opportunities ahead and lead ConvaTec in achieving our goal of becoming the growth leader in each of our markets and key business areas."

Prior to joining ConvaTec, Moraviec was Chief Executive Officer of Prosurgics Limited, a surgical robotics company. Prior to this, Moraviec held the position of Vice President, International Commercial Operations for Abbott Laboratories Diabetes Care Division, where he was responsible for transforming the performance of the business to sales of $700M and a strong growth and profitability profile. In addition, Moraviec has held the positions of CEO of IIT Ltd, a UK medical device start-up company and Vice President, International Sales and Marketing for Codman, a Johnson & Johnson medical devices and diagnostics company.

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions - Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices - ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. ConvaTec is owned by Nordic Capital and Avista Capital Partners. For more information, please visit www.convatec.com.

Contact

    Punnie Donohue
    ConvaTec
    Phone: 908-904-2151
    Punnie.Donohue@convatec.com


'/>"/>
SOURCE ConvaTec
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
2. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
3. ConvaTec Launches New Lifestyle Magazine for People With an Ostomy
4. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
5. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
6. Redstone Highlands Names WordWrite Communications Agency of Record
7. Cantel Medical Corp. Names Andrew Krakauer as CEO and Announces Other Corporate Appointments
8. Northern California Cancer Center Study Seeks to Improve Colon Cancer Screening in Vietnamese Communities
9. Codexis Names Sarret SVP, Corporate Development
10. Irelands Allergy Standards Limited Adds Two New U.S. Names to Line-Up of Companies Making Allergy-Certified Consumer Products
11. New Corporate Agreement with Legacy Hospital Partners, Inc. Names Broadlane Exclusive Provider of Supply Chain and Procurement Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... , ... CareSet Labs released the Root NPI Graph today at the 2017 ... improved version of the Doctor Referral teaming dataset commonly available from Medicare. , Originally ... the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released by ...
(Date:6/25/2017)... ... June 25, 2017 , ... June is Men’s Health Month and the focus is ... among men in the U.S. and the third most common cause of cancer related death ... man in seven will be diagnosed with prostate cancer during his lifetime. Those at ...
(Date:6/24/2017)... ... June 24, 2017 , ... The Pennsylvania Athletic Trainers’ Society’s ... and Erie Convention Center on June 8-10. The weekend consisted of many ... award and scholarship presentations, and professional networking. , On Friday June 9th, ...
(Date:6/24/2017)... , ... June 24, 2017 , ... The weather is ... time outdoors. Home and business owners should be aware that the summer months provide ... In fact, mechanical locks and keys can be negatively affected from direct exposure to ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... today announced the launch of Care Management Alerts and Dashboards, an innovative new ... throughout Rhode Island. , RIQI’s Care Management Alerts and Dashboards provide near real-time ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... Calif. , June 14, 2017 The ... the City of Fremont and ... of the bio-pharma industry in California ... technology, enabling executive networking, and fostering workforce development. The ... development and growth of start-ups, as well as small ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
Breaking Medicine Technology: